Enkang
Latest round
- Series B
Last raised
- Jan 2023
Total raised
- Undisclosed
Investors
- 1
About Enkang
Founded in 2017 and based in Guangzhou, China, Enkang is a pharmaceutical technology company that focuses on the development of anti-cancer drugs. The company has R&D laboratories and product pilot workshops in Hong Kong, Macao, Guangzhou and Foshan. By 2023, it has applied for 15 invention patents at home and abroad, including 7 patents. Chun Liang, the founder, chairman and chief scientist of the company, is now a tenured professor of the life sciences department of the Hong Kong University of Science and Technology and the director of the Cancer Research Center of the Hong Kong University of Science and Technology. The company's main business is the R & D of innovative anti-cancer drugs and pharmaceutical formulations. The company's self-developed products include the inhaled liposome drug ILC (Inhaled Lipid Cisplatin) for small cell lung cancer and the DRIPs inhibitor EN002 gel for non-melanoma skin cancer and pre-cancer lesions. It also has two R & D platforms: the inhaled liposome formulation platform and the DRIP (DNA replication initiation protein) inhibitor-targeted tumor drug screening platform. Its products are used in the field of oncology for cancer treatment.
Who invested in Enkang
1 investor across 1 round
See all investors in Enkang
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 30, 2023
Amount
Undisclosed
Investors
Questions about Enkang
Who invested in Enkang?
Enkang has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enkang raised?
Enkang has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Enkang last raise money?
Enkang's most recent round on record is a Series B, in Jan 2023.
What does Enkang do?
Founded in 2017 and based in Guangzhou, China, Enkang is a pharmaceutical technology company that focuses on the development of anti-cancer drugs.
Where is Enkang headquartered?
Enkang is headquartered in Guangzhou, China.
Which VCs invest in companies like Enkang?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Enkang's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Enkang? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.